NCT00658255View on ClinicalTrials.gov

Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler

PHASE2CompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

May 31, 2003

Conditions
Stable Asthma
Interventions
DRUG

budesonide/formoterol

DRUG

formoterol

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY